Abstracts for Poster Presentation
P1 - The Impact of the EU Clinical Trials Regulation (CTR)
P2 - Plain-language summaries of publications - Who, what, when, where, and why?
P3 - Medical Writers: A Pivotal Role in Leading Teams to Compliance with EU CTR Transparency Requirements
P4 - Working Across Therapeutic Areas – Boon or a Challenge for MWs?
P5 - Turning waterfalls into swirls – can regulatory MW transform into agile MW?
P6 - Regulatory framework for nanotechnology in medical devices
P7 - Growing Role of Regulatory Medical Writers in Driving and Optimising Submissions
P8 - The trends of ChatGPT using in medical writing: Results from a KAP survey
P9 - Analysis of adverse events in early phase trials. A medical writing perspective
P10 - Exploring the awareness and perceived utility of graphical abstracts in scientific publishing
P13 - Preparation is Key to Success: Use of the Document Content and Messaging Summary (DCAMS) in Authoring Regulatory Submission Documents
P15 - Maximizing quality control review of regulatory documents
P16 - An attempt to translate estimands into plain language
P19 - Plain language summaries created with Artificial intelligence - Can it save time or waste it?
P20 - Videocast(s): Are they worth the effort as a digital enhancement?
P21 - The Art and Science of Medical Writing amidst Technological Innovations
P22 - Enhancing Patient-Centricity in Medical Writing: the Art and Science of Effective Plain Language Summaries
P23 - Quantifying sex bias in randomized clinical trials of major impact publications